CSIMarket
 

Fibrogen Inc   (FGEN)
Other Ticker:  
 

Fibrogen Inc 's Working Capital Per Sales

FGEN's Working Capital and Revenue growth



FGEN Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -30.39 % -22.48 % -34.66 % -11.79 % -38.96 %
Y / Y Revenue Change 155.06 % 48.69 % -40.55 % 107.74 % -89.91 %
Working Capital Per Revenue 1.24 1.6 1.93 1.76 2.07
Total Ranking # 2767 # 1571 # 1571 # 1571 # 1571
Seq. Working Capital Change -28.81 % 23.6 % -19.82 % -1.33 % -20.72 %
Seq. Revenue Change -9.44 % 22.56 % 5.22 % 118.4 % -47.21 %





Comment on FGEN's Working Capital Per Revenue in the third quarter 2023
Fibrogen Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 1.24 below the company average.

Within Healthcare sector 83 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2023, compared to previous quarter from 1571 to 2767.
Working Capital Per Revenue Ranking
Within: No.
Industry # 30
Sector # 84
S&P 500 # 2767


Working Capital Per Revenue Statistics
High Average Low
6.04
2.62
0.98
(Jun 30 2020)   (Dec 31 2016)



Financial Statements
Fibrogen Inc 's Working Capital $ 155 Millions Visit FGEN's Balance sheet
Fibrogen Inc 's Revenues $ 40 Millions Visit FGEN's Income Statement
Where are FGEN's Sales coming from? Visit FGEN's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Neurometrix Inc   3.31 
Nurix Therapeutics Inc   3.26 
Cvrx inc   3.14 
Tivic Health Systems Inc   3.12 
Denali Therapeutics Inc   3.06 
Quanterix Corp  3.05 
Cartesian Therapeutics Inc   2.88 
Insmed Inc  2.86 
Therapeuticsmd Inc   2.83 
Bionano Genomics Inc   2.82 
Iterum Therapeutics Plc  2.77 
Neuroone Medical Technologies Corporation  2.70 
Regenxbio Inc   2.67 
Eyepoint Pharmaceuticals Inc   2.60 
Apellis Pharmaceuticals Inc   2.47 
Nanovibronix Inc  2.40 
Biocardia Inc  2.36 
Aurinia Pharmaceuticals Inc   2.34 
Carisma Therapeutics Inc   2.32 
Schrodinger Inc   2.31 
Cryoport inc   2.31 
Pulmonx Corporation  2.30 
Aravive Inc   2.23 
Precision Biosciences Inc  2.23 
Deciphera Pharmaceuticals Inc   2.22 
Adaptive Biotechnologies Corporation  2.21 
Adaptimmune Therapeutics Plc  2.21 
Sight Sciences Inc   2.13 
Nuo Therapeutics Inc   2.11 
Travere Therapeutics Inc   2.11 
Date modified: 2023-11-07T13:07:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com